Clinical Trials Browser

Completed × PX-866 × Clear all

NCT01259869 2023-08-22

A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

Phase 2 Completed

34 enrolled 7 charts

Glioblastoma

NCT01331083 2023-08-22

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

68 enrolled 11 charts

Prostatic Neoplasms

NCT00726583 2018-05-17

Phase I Trial of Oral PX-866

Phase 1 Completed

Carcinoma, Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT01204099 2018-05-16

Study of PX-866 and Docetaxel in Solid Tumors

Phase 1/2 Completed

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Hereditary Sensory and Autonomic Neuropathies

NCT01252628 2018-05-16

Phase 1 and 2 Study of PX-866 and Cetuximab

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Squamous Cell, Hereditary Sensory and Autonomic Neuropathies, Recurrence, Colorectal Neoplasms